KT5720
Appearance
Names | |
---|---|
IUPAC name
(5R,6S,8S)-Hexyl 6-hydroxy-5-methyl-13-oxo-6,7,8,13,14,15-hexahydro-5H-16-oxa-4b,8a,14-triaza-5,8-methanodibenzo[b,h]cycloocta[jkl]cyclopenta[e]-as-indacene-6-carboxylate
| |
Other names
KT 5720
| |
Identifiers | |
3D model (JSmol)
|
|
ChEBI | |
ChemSpider | |
ECHA InfoCard | 100.238.838 |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C32H31N3O5 | |
Molar mass | 537.616 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
KT5720 is a kinase inhibitor with specificity towards protein kinase A.[1] It is a semi-synthetic derivative of K252a[2] and analog of staurosporine.
References
[edit]- ^ Makarevich, A. V.; Sirotkin, A. V.; Rafay, J. (2010). "Comparison of Effects of Protein Kinase A, Mitogen-activated Protein Kinase, and Cyclin-dependent Kinase Blockers on Rabbit Ovarian Granulosa Cell Functions". Hormone and Metabolic Research. 42 (13): 936–43. doi:10.1055/s-0030-1267226. PMID 20972940.
- ^ CID 3844 from PubChem